UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.

It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...

A civilian jet broke the sound barrier for the first time Tuesday while making a historic test flight over the Mojave Desert. The XB-1 aircraft, manufactured by Boom Supersonic, was piloted by ...

To study with us, all home, EU and overseas applicants must demonstrate they meet the required English language competency level for their chosen course. The requirements for meeting the standard or ...